Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Subscribe To Our Newsletter & Stay Updated
